📊 poll results
Moderna Stock Nearly Triples in a Day -- Cancer Breakthrough, Flu Shot Win, or Just a Short Squeeze?
🏆 Leading: This is mostly a short squeeze and momentum rally -- with $5.5B in shorts getting burned, the stock's valuation has now outrun its actual shrinking sales

This is mostly a short squeeze and momentum rally -- with $5.5B in shorts getting burned, the stock's valuation has now outrun its actual shrinking sales is leading so far with 100%.

Everyone who has answered so far is voting from China.

The poll is still live and picked up a vote today.

hewsay who say wut? 💬
📊 poll results
Moderna Stock Nearly Triples in a Day -- Cancer Breakthrough, Flu Shot Win, or Just a Short Squeeze?
100%
Leading answer
This is mostly a short squeeze and momentum rally -- with $5.5B in shorts getting burned, the stock's valuation has now outrun its actual shrinking sales
results so far
hewsay.com ↗

Discussion

Vote on one of these nextModerna Stock Exploded 177% in One Day on a Cancer Vaccine Breakthrough -- Is This Justified Science, Pure Hype, or a Short-Squeeze Overreaction?Fauci's Former Top Science Adviser Pleads Guilty to Hiding COVID Records -- Accountability, the Tip of the Iceberg, or Overblown?Grok 4.6, Claude Opus 5, Cursor Ultra, Apple's M6 chip - which of this month's releases actually matters?
react to this tea 👀
The cancer vaccine data is a legitimate scientific breakthrough -- a personalized mRNA shot that meaningfully delays melanoma recurrence changes the long-term story for Moderna
The mFlusiva flu vaccine approval matters just as much -- it proves Moderna's mRNA platform can succeed well beyond COVID, diversifying its revenue base
This is mostly a short squeeze and momentum rally -- with $5.5B in shorts getting burned, the stock's valuation has now outrun its actual shrinking sales